Amazon takes another shot at healthcare, this one a virtual care service that costs US$9 per monthThe e-commerce giant says its Prime customers can now get quick access to a healthcare provider through a program that costs US$9 a month or US$99 annually. Man receives the first eye transplant plus a new face. It’s a step toward one day restoring sightAn accident with high-voltage power lines had destroyed most of Aaron James’ face and one eye. U.S. FDA approves new version of diabetes drug Mounjaro for weight loss Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. ChatGPT: an ally in dealing with vaccine hesitancy AI chatbot scores in answering the 50 most frequently asked questions about COVID-19 vaccinations. Vaccine paves the way for new treatments for allergies A Franco-Quebec company is currently testing a vaccine that could treat human cat allergy and other common allergies in the future. Once-weekly Mounjaro now available in Canada for treatment of type 2 diabetes Tirzepatide, the first “twincretin,” reduces A1C and body weight in adults with type 2 diabetes. A PCR test to clarify the prognosis of prostate cancer Montreal researchers identify genetic biomarkers that could make it possible to better target treatment. AI to identify the primary site of cancer? Using machine learning, AI model was trained to recognize 22 most common types of cancer from tumors taken from 30,000 patients. Death of a player from a skate to the neck reignites hockey’s stubborn debate over protective gear Broken jaws, smashed noses and concussions haven’t led to full face shields or cages in professional men’s hockey at any level, either. Health Canada says cord blood stored at Edmonton facility may pose serious risks The warning affects all cord blood at the Canadian Cord Blood bioRepository that was collected, processed, tested or stored between March 1, 2014, and present. First Previous 88 89 90 91 92 Next Last
